S2 E5 - What We Learned at Today's FDA Webcast on NASH Drug Development
Send us Fan Mail Manal Abdelmalek, Naim Alkhouri, and Akero Therapeutics Chief Development Officer Kitty Yale join the Surfers to discuss Friday's FDA webcast on NASH Drug Development. Friday's FDA W...
1 Feb 20211h 9min
S2 E4 - What to Listen For Friday at the FDA Webcast
Send us Fan Mail Manal Abdelmalek joins the Surfers to share expectations in advance of Friday's FDA Webcast on NASH Drug Development. FDA's Friday webcast titled "Regulatory Perspectives for Develop...
28 Jan 202151min
S2 E3.2 - Call to action: Can We use COVID-19 Vaccine Centers to support Liver health?
Send us Fan Mail The Surfers discuss ways that COVID-19 Vaccine Centers might present an opportunity to educate and screen patients on Liver Health Stephen Harrison suggests that COVID-19 Vaccine Cen...
23 Jan 202124min
S2 E3.1 - Challenges Disadvantaged Minorities Face in Liver Health
Send us Fan Mail Donna Cryer and Louise Campbell discuss how governmental action (or inaction) couple with community efforts to shape Liver Health initiatives in the US, UK, and Australia. The Surfer...
23 Jan 202125min
S2 E3 A Call to Action on MLK Day: Supporting disadvantaged Minorities in Managing Liver Health
Send us Fan Mail Donna Cryer joins the Surfers to explore efforts to support residents in disadvantaged minority communities in the US, UK, and Australia in improving their Liver Health and awareness....
21 Jan 202152min
S2 E2.3 - Partners and enablers Necessary to Help Drive Broader NAFLD and Non-Communicable Disease
Send us Fan Mail The Surfers end this episode by discussing the need for public education to create the awareness necessary for change. This conversation covers a broad range of topics -- public heal...
16 Jan 202113min
S2 E2.2 - Economic and Patient Motivation Costs and Value of telemedicine and New Non-Invasive Diagnostic Testing
Send us Fan Mail Evaluating the economic and patient-motivating value of enhanced telemedicine and mobile non-invasive testing technologies in improving NAFLD diagnosis and lowering rates of non-commu...
16 Jan 202115min
S2 E2.1 - Innovations in Telemedicine and Mobile Technology can improve care for NAFLD patients
Send us Fan Mail Innovations in Telemedicine and Mobile Technologies are already changing patient care in ways that will remain and expand in the "New Normal" after the COVID-19 pandemic is less urgen...
16 Jan 202120min
